Pharmacy Daily | MHRA waves flag

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is claiming to be at the “forefront of a global drive to improve public health”, going “further and deeper in leading the international community to implement reforms” according to its own ‘Triennial Review’ of itself. The Review links into MHRA’s business plan including progressing work on key EU negotiations and implementation relating to clinical trials, falsified medicines and medical devices as well as closer collaboration with the UK Department of Health and partners in the health and care system, working towards common goals. In addition the MHRA’s agenda is also driven by the need to further develop excellence in science, including developing the capabilities of the National Institute for Biological Standards and Control (NIBSC) to ensure it remains a global leader in standardisation and control of biological medicines as well as improving and enhancing incident and safety reporting systems, principally the Yellow Card Scheme (PD 16 Jul). CLICK HERE to access the report.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 23 Jul 15
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Jul 15